4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-22-005599
Options or other derivatives
- Interim CEO & General Counsel acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Vogt Frederick G Interim CEO & General Counsel | 2022-01-14 | Grant or award · Restricted Stock Units | +250,000 | 250,000 | D | ||
Loading xslF345X03/tm223806-4_4seq1.xml…